NCT00002876View on ClinicalTrials.gov

Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

October 31, 1991

Primary Completion Date

April 30, 1998

Study Completion Date

January 31, 2005

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

cisplatin

DRUG

etoposide

Trial Locations (3)

32224

Mayo Clinic Jacksonville, Jacksonville

55905

Mayo Clinic Cancer Center, Rochester

85259

Mayo Clinic Scottsdale, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER